Viewing Study NCT05262556


Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2026-01-01 @ 5:20 PM
Study NCT ID: NCT05262556
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-07
First Post: 2022-02-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas
Sponsor: Amr Mohamed MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module